Milestone Pharmaceuticals
Price & Volume
Stats
See moreOpen | $2 |
Previous Close | $2 |
Day Range | $2-$2.10 |
52W Range | $0.62-$2.75 |
Market Cap | $169.9M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.84 |
News
See moreYahoo Finance • 12 hours ago
Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025
Yahoo Finance • 2 months ago
Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Yahoo Finance • 3 months ago
Milestone Pharmaceuticals Launches Public Offering To Support Etripamil Development
Yahoo Finance • 3 months ago
Milestone Pharmaceuticals prices $52.5 million public offering
About
CEO | Mr. Joseph G. Oliveto M.B.A. |
CFO | Mr. Amit Hasija |
Address | 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 33 |
